119 related articles for article (PubMed ID: 6435915)
1. Sodium taurocholate effect on beta-glucosidase activity: a new approach for identification of Gaucher disease using the synthetic substrate and leucocytes.
Magalhães J; Sá Miranda MC; Pinto R; Lemos M; Poenaru L
Clin Chim Acta; 1984 Aug; 141(2-3):111-8. PubMed ID: 6435915
[TBL] [Abstract][Full Text] [Related]
2. Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.
Wenger DA; Clark C; Sattler M; Wharton C
Clin Genet; 1978 Feb; 13(2):145-53. PubMed ID: 23912
[TBL] [Abstract][Full Text] [Related]
3. An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.
Daniels LB; Glew RH; Diven WF; Lee RE; Radin NS
Clin Chim Acta; 1981 Sep; 115(3):369-75. PubMed ID: 6794954
[TBL] [Abstract][Full Text] [Related]
4. Heterozygote detection of type I Gaucher disease using blood platelets.
Nakagawa S; Kumin S; Sachs G; Nitowsky HM
Clin Chim Acta; 1982 Jan; 118(1):99-107. PubMed ID: 6797762
[TBL] [Abstract][Full Text] [Related]
5. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
Choy FY; Davidson RG
Pediatr Res; 1980 Jan; 14(1):54-9. PubMed ID: 6767218
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.
Raghavan SS; Topol J; Kolodny EH
Am J Hum Genet; 1980 Mar; 32(2):158-73. PubMed ID: 6770675
[TBL] [Abstract][Full Text] [Related]
7. Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes.
Butcher BA; Gopalan V; Lee RE; Richards TC; Waggoner AS; Glew RH
Clin Chim Acta; 1989 Oct; 184(3):235-42. PubMed ID: 2515009
[TBL] [Abstract][Full Text] [Related]
8. Assay of the beta-glucosidase activity with natural labelled and artificial substrates in leukocytes from homozygotes and heterozygotes with the Norrbottnian type (Type 3) of Gaucher disease.
Svennerholm L; Håkansson G; Dreborg S
Clin Chim Acta; 1980 Sep; 106(2):183-93. PubMed ID: 6773705
[TBL] [Abstract][Full Text] [Related]
9. Comparison of various beta-glucosidase assays used to diagnose Gaucher's disease.
Chiao YB; Glew RH; Diven WF; Lee RE
Clin Chim Acta; 1980 Jul; 105(1):41-50. PubMed ID: 6772352
[No Abstract] [Full Text] [Related]
10. [Laboratory diagnosis of Gaucher's disease. Value of leukocyte beta-glucosidase determination].
Turpin JC; Bauman N; Castaigne P
Nouv Presse Med; 1972 Jun; 1(23):1579-81. PubMed ID: 5035886
[No Abstract] [Full Text] [Related]
11. Multiple forms of membrane-bound beta-glucosidase in human leucocytes.
Carroll M
Biochem Soc Trans; 1981 Feb; 9(1):129-30. PubMed ID: 6783452
[No Abstract] [Full Text] [Related]
12. Heterozygote detection of type I Gaucher disease using blood platelets.
Nakagawa S; Kumin S; Sachs G; Nitowsky HM
Prog Clin Biol Res; 1982; 95():597-602. PubMed ID: 6812088
[No Abstract] [Full Text] [Related]
13. A microassay for Gaucher's disease.
Peters SP; Lee RE; Glew RH
Clin Chim Acta; 1975 May; 60(3):391-6. PubMed ID: 806404
[TBL] [Abstract][Full Text] [Related]
14. Assay of beta-glucosidase and sphingomyelinase for identification of patients and carriers of Gaucher's and Niemann-Pick diseases.
Wenger DA
Adv Exp Med Biol; 1978; 101():707-17. PubMed ID: 208369
[No Abstract] [Full Text] [Related]
15. The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.
Beutler E; Kuhl W
J Lab Clin Med; 1970 Nov; 76(5):747-55. PubMed ID: 5477334
[No Abstract] [Full Text] [Related]
16. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
[TBL] [Abstract][Full Text] [Related]
17. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
Grabowski GA; Goldblatt J; Dinur T; Kruse J; Svennerholm L; Gatt S; Desnick RJ
Am J Med Genet; 1985 Jul; 21(3):529-49. PubMed ID: 3927728
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Gaucher's disease in cultured skin fibroblasts and leucocytes.
Butterworth J; Broadhead DM
J Inherit Metab Dis; 1978; 1(3):111-3. PubMed ID: 116079
[TBL] [Abstract][Full Text] [Related]
19. beta-Glucosidase assays in the diagnosis of Gaucher's disease.
Daniels LB; Glew RH
Clin Chem; 1982 Apr; 28(4 Pt 1):569-77. PubMed ID: 6804115
[TBL] [Abstract][Full Text] [Related]
20. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
Choy FY; Bouillon L; Laurin CA
Am J Med Genet; 1987 Aug; 27(4):895-905. PubMed ID: 3425599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
